Avitas Wealth Management’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-11,817
Closed -$437K 181
2019
Q1
$437K Sell
11,817
-713
-6% -$26.4K 0.13% 145
2018
Q4
$540K Buy
+12,530
New +$540K 0.18% 130